Global Interventional Lung Disease Market Growth 2025-2031

December 2025 | 125 pages | ID: GBBF3012C35EN
LP Information

Abstracts

The global Interventional Lung Disease market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Interventional pulmonology is a relatively new field in pulmonary medicine. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest.

United States market for Interventional Lung Disease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Interventional Lung Disease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Interventional Lung Disease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Interventional Lung Disease players cover Boston Scientific, Olympus, FUJIFILM, Becton, Dickinson and Company, Smiths Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Interventional Lung Disease Industry Forecast” looks at past sales and reviews total world Interventional Lung Disease sales in 2024, providing a comprehensive analysis by region and market sector of projected Interventional Lung Disease sales for 2025 through 2031. With Interventional Lung Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Lung Disease industry.

This Insight Report provides a comprehensive analysis of the global Interventional Lung Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Lung Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interventional Lung Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Lung Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Lung Disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Lung Disease market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Bronchoscopes
• Respiratory Endotherapy Devices
• ENB Systems
• Pleuroscopes
• Other

Segmentation by Application:

• Hospital
• Emergency Center
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Boston Scientific
• Olympus
• FUJIFILM
• Becton, Dickinson and Company
• Smiths Group
• Cook Medical
• Vygon
• PENTAX Medical
• Clarus Medical
• HUGER Medical Instrument
• Richard Wolf
• Karl Storz
• Taewoong Medical
• ELLA - CS

Key Questions Addressed in this Report

What is the 10-year outlook for the global Interventional Lung Disease market?

What factors are driving Interventional Lung Disease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Interventional Lung Disease market opportunities vary by end market size?

How does Interventional Lung Disease break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Interventional Lung Disease Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Interventional Lung Disease by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Interventional Lung Disease by Country/Region, 2020, 2024 & 2031
2.2 Interventional Lung Disease Segment by Type
  2.2.1 Bronchoscopes
  2.2.2 Respiratory Endotherapy Devices
  2.2.3 ENB Systems
  2.2.4 Pleuroscopes
  2.2.5 Other
2.3 Interventional Lung Disease Sales by Type
  2.3.1 Global Interventional Lung Disease Sales Market Share by Type (2020-2025)
  2.3.2 Global Interventional Lung Disease Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Interventional Lung Disease Sale Price by Type (2020-2025)
2.4 Interventional Lung Disease Segment by Application
  2.4.1 Hospital
  2.4.2 Emergency Center
  2.4.3 Clinic
2.5 Interventional Lung Disease Sales by Application
  2.5.1 Global Interventional Lung Disease Sale Market Share by Application (2020-2025)
  2.5.2 Global Interventional Lung Disease Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Interventional Lung Disease Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Interventional Lung Disease Breakdown Data by Company
  3.1.1 Global Interventional Lung Disease Annual Sales by Company (2020-2025)
  3.1.2 Global Interventional Lung Disease Sales Market Share by Company (2020-2025)
3.2 Global Interventional Lung Disease Annual Revenue by Company (2020-2025)
  3.2.1 Global Interventional Lung Disease Revenue by Company (2020-2025)
  3.2.2 Global Interventional Lung Disease Revenue Market Share by Company (2020-2025)
3.3 Global Interventional Lung Disease Sale Price by Company
3.4 Key Manufacturers Interventional Lung Disease Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Interventional Lung Disease Product Location Distribution
  3.4.2 Players Interventional Lung Disease Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INTERVENTIONAL LUNG DISEASE BY GEOGRAPHIC REGION

4.1 World Historic Interventional Lung Disease Market Size by Geographic Region (2020-2025)
  4.1.1 Global Interventional Lung Disease Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Interventional Lung Disease Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Interventional Lung Disease Market Size by Country/Region (2020-2025)
  4.2.1 Global Interventional Lung Disease Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Interventional Lung Disease Annual Revenue by Country/Region (2020-2025)
4.3 Americas Interventional Lung Disease Sales Growth
4.4 APAC Interventional Lung Disease Sales Growth
4.5 Europe Interventional Lung Disease Sales Growth
4.6 Middle East & Africa Interventional Lung Disease Sales Growth

5 AMERICAS

5.1 Americas Interventional Lung Disease Sales by Country
  5.1.1 Americas Interventional Lung Disease Sales by Country (2020-2025)
  5.1.2 Americas Interventional Lung Disease Revenue by Country (2020-2025)
5.2 Americas Interventional Lung Disease Sales by Type (2020-2025)
5.3 Americas Interventional Lung Disease Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Interventional Lung Disease Sales by Region
  6.1.1 APAC Interventional Lung Disease Sales by Region (2020-2025)
  6.1.2 APAC Interventional Lung Disease Revenue by Region (2020-2025)
6.2 APAC Interventional Lung Disease Sales by Type (2020-2025)
6.3 APAC Interventional Lung Disease Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Interventional Lung Disease by Country
  7.1.1 Europe Interventional Lung Disease Sales by Country (2020-2025)
  7.1.2 Europe Interventional Lung Disease Revenue by Country (2020-2025)
7.2 Europe Interventional Lung Disease Sales by Type (2020-2025)
7.3 Europe Interventional Lung Disease Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Interventional Lung Disease by Country
  8.1.1 Middle East & Africa Interventional Lung Disease Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Interventional Lung Disease Revenue by Country (2020-2025)
8.2 Middle East & Africa Interventional Lung Disease Sales by Type (2020-2025)
8.3 Middle East & Africa Interventional Lung Disease Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Lung Disease
10.3 Manufacturing Process Analysis of Interventional Lung Disease
10.4 Industry Chain Structure of Interventional Lung Disease

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Interventional Lung Disease Distributors
11.3 Interventional Lung Disease Customer

12 WORLD FORECAST REVIEW FOR INTERVENTIONAL LUNG DISEASE BY GEOGRAPHIC REGION

12.1 Global Interventional Lung Disease Market Size Forecast by Region
  12.1.1 Global Interventional Lung Disease Forecast by Region (2026-2031)
  12.1.2 Global Interventional Lung Disease Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Interventional Lung Disease Forecast by Type (2026-2031)
12.7 Global Interventional Lung Disease Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Boston Scientific
  13.1.1 Boston Scientific Company Information
  13.1.2 Boston Scientific Interventional Lung Disease Product Portfolios and Specifications
  13.1.3 Boston Scientific Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Boston Scientific Main Business Overview
  13.1.5 Boston Scientific Latest Developments
13.2 Olympus
  13.2.1 Olympus Company Information
  13.2.2 Olympus Interventional Lung Disease Product Portfolios and Specifications
  13.2.3 Olympus Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Olympus Main Business Overview
  13.2.5 Olympus Latest Developments
13.3 FUJIFILM
  13.3.1 FUJIFILM Company Information
  13.3.2 FUJIFILM Interventional Lung Disease Product Portfolios and Specifications
  13.3.3 FUJIFILM Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 FUJIFILM Main Business Overview
  13.3.5 FUJIFILM Latest Developments
13.4 Becton, Dickinson and Company
  13.4.1 Becton, Dickinson and Company Company Information
  13.4.2 Becton, Dickinson and Company Interventional Lung Disease Product Portfolios and Specifications
  13.4.3 Becton, Dickinson and Company Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Becton, Dickinson and Company Main Business Overview
  13.4.5 Becton, Dickinson and Company Latest Developments
13.5 Smiths Group
  13.5.1 Smiths Group Company Information
  13.5.2 Smiths Group Interventional Lung Disease Product Portfolios and Specifications
  13.5.3 Smiths Group Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Smiths Group Main Business Overview
  13.5.5 Smiths Group Latest Developments
13.6 Cook Medical
  13.6.1 Cook Medical Company Information
  13.6.2 Cook Medical Interventional Lung Disease Product Portfolios and Specifications
  13.6.3 Cook Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Cook Medical Main Business Overview
  13.6.5 Cook Medical Latest Developments
13.7 Vygon
  13.7.1 Vygon Company Information
  13.7.2 Vygon Interventional Lung Disease Product Portfolios and Specifications
  13.7.3 Vygon Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Vygon Main Business Overview
  13.7.5 Vygon Latest Developments
13.8 PENTAX Medical
  13.8.1 PENTAX Medical Company Information
  13.8.2 PENTAX Medical Interventional Lung Disease Product Portfolios and Specifications
  13.8.3 PENTAX Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 PENTAX Medical Main Business Overview
  13.8.5 PENTAX Medical Latest Developments
13.9 Clarus Medical
  13.9.1 Clarus Medical Company Information
  13.9.2 Clarus Medical Interventional Lung Disease Product Portfolios and Specifications
  13.9.3 Clarus Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Clarus Medical Main Business Overview
  13.9.5 Clarus Medical Latest Developments
13.10 HUGER Medical Instrument
  13.10.1 HUGER Medical Instrument Company Information
  13.10.2 HUGER Medical Instrument Interventional Lung Disease Product Portfolios and Specifications
  13.10.3 HUGER Medical Instrument Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 HUGER Medical Instrument Main Business Overview
  13.10.5 HUGER Medical Instrument Latest Developments
13.11 Richard Wolf
  13.11.1 Richard Wolf Company Information
  13.11.2 Richard Wolf Interventional Lung Disease Product Portfolios and Specifications
  13.11.3 Richard Wolf Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Richard Wolf Main Business Overview
  13.11.5 Richard Wolf Latest Developments
13.12 Karl Storz
  13.12.1 Karl Storz Company Information
  13.12.2 Karl Storz Interventional Lung Disease Product Portfolios and Specifications
  13.12.3 Karl Storz Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Karl Storz Main Business Overview
  13.12.5 Karl Storz Latest Developments
13.13 Taewoong Medical
  13.13.1 Taewoong Medical Company Information
  13.13.2 Taewoong Medical Interventional Lung Disease Product Portfolios and Specifications
  13.13.3 Taewoong Medical Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Taewoong Medical Main Business Overview
  13.13.5 Taewoong Medical Latest Developments
13.14 ELLA - CS
  13.14.1 ELLA - CS Company Information
  13.14.2 ELLA - CS Interventional Lung Disease Product Portfolios and Specifications
  13.14.3 ELLA - CS Interventional Lung Disease Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 ELLA - CS Main Business Overview
  13.14.5 ELLA - CS Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Interventional Lung Disease Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Interventional Lung Disease Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Bronchoscopes
Table 4. Major Players of Respiratory Endotherapy Devices
Table 5. Major Players of ENB Systems
Table 6. Major Players of Pleuroscopes
Table 7. Major Players of Other
Table 8. Global Interventional Lung Disease Sales by Type (2020-2025) & (K Units)
Table 9. Global Interventional Lung Disease Sales Market Share by Type (2020-2025)
Table 10. Global Interventional Lung Disease Revenue by Type (2020-2025) & ($ million)
Table 11. Global Interventional Lung Disease Revenue Market Share by Type (2020-2025)
Table 12. Global Interventional Lung Disease Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Interventional Lung Disease Sale by Application (2020-2025) & (K Units)
Table 14. Global Interventional Lung Disease Sale Market Share by Application (2020-2025)
Table 15. Global Interventional Lung Disease Revenue by Application (2020-2025) & ($ million)
Table 16. Global Interventional Lung Disease Revenue Market Share by Application (2020-2025)
Table 17. Global Interventional Lung Disease Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Interventional Lung Disease Sales by Company (2020-2025) & (K Units)
Table 19. Global Interventional Lung Disease Sales Market Share by Company (2020-2025)
Table 20. Global Interventional Lung Disease Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Interventional Lung Disease Revenue Market Share by Company (2020-2025)
Table 22. Global Interventional Lung Disease Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Interventional Lung Disease Producing Area Distribution and Sales Area
Table 24. Players Interventional Lung Disease Products Offered
Table 25. Interventional Lung Disease Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Interventional Lung Disease Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Interventional Lung Disease Sales Market Share Geographic Region (2020-2025)
Table 30. Global Interventional Lung Disease Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Interventional Lung Disease Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Interventional Lung Disease Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Interventional Lung Disease Sales Market Share by Country/Region (2020-2025)
Table 34. Global Interventional Lung Disease Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Interventional Lung Disease Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Interventional Lung Disease Sales by Country (2020-2025) & (K Units)
Table 37. Americas Interventional Lung Disease Sales Market Share by Country (2020-2025)
Table 38. Americas Interventional Lung Disease Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Interventional Lung Disease Sales by Type (2020-2025) & (K Units)
Table 40. Americas Interventional Lung Disease Sales by Application (2020-2025) & (K Units)
Table 41. APAC Interventional Lung Disease Sales by Region (2020-2025) & (K Units)
Table 42. APAC Interventional Lung Disease Sales Market Share by Region (2020-2025)
Table 43. APAC Interventional Lung Disease Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Interventional Lung Disease Sales by Type (2020-2025) & (K Units)
Table 45. APAC Interventional Lung Disease Sales by Application (2020-2025) & (K Units)
Table 46. Europe Interventional Lung Disease Sales by Country (2020-2025) & (K Units)
Table 47. Europe Interventional Lung Disease Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Interventional Lung Disease Sales by Type (2020-2025) & (K Units)
Table 49. Europe Interventional Lung Disease Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Interventional Lung Disease Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Interventional Lung Disease Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Interventional Lung Disease Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Interventional Lung Disease Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Interventional Lung Disease
Table 55. Key Market Challenges & Risks of Interventional Lung Disease
Table 56. Key Industry Trends of Interventional Lung Disease
Table 57. Interventional Lung Disease Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Interventional Lung Disease Distributors List
Table 60. Interventional Lung Disease Customer List
Table 61. Global Interventional Lung Disease Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Interventional Lung Disease Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Interventional Lung Disease Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Interventional Lung Disease Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Interventional Lung Disease Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Interventional Lung Disease Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Interventional Lung Disease Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Interventional Lung Disease Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Interventional Lung Disease Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Interventional Lung Disease Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Interventional Lung Disease Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Interventional Lung Disease Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Interventional Lung Disease Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Interventional Lung Disease Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Boston Scientific Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 76. Boston Scientific Interventional Lung Disease Product Portfolios and Specifications
Table 77. Boston Scientific Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Boston Scientific Main Business
Table 79. Boston Scientific Latest Developments
Table 80. Olympus Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 81. Olympus Interventional Lung Disease Product Portfolios and Specifications
Table 82. Olympus Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Olympus Main Business
Table 84. Olympus Latest Developments
Table 85. FUJIFILM Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 86. FUJIFILM Interventional Lung Disease Product Portfolios and Specifications
Table 87. FUJIFILM Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. FUJIFILM Main Business
Table 89. FUJIFILM Latest Developments
Table 90. Becton, Dickinson and Company Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 91. Becton, Dickinson and Company Interventional Lung Disease Product Portfolios and Specifications
Table 92. Becton, Dickinson and Company Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Becton, Dickinson and Company Main Business
Table 94. Becton, Dickinson and Company Latest Developments
Table 95. Smiths Group Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 96. Smiths Group Interventional Lung Disease Product Portfolios and Specifications
Table 97. Smiths Group Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Smiths Group Main Business
Table 99. Smiths Group Latest Developments
Table 100. Cook Medical Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 101. Cook Medical Interventional Lung Disease Product Portfolios and Specifications
Table 102. Cook Medical Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cook Medical Main Business
Table 104. Cook Medical Latest Developments
Table 105. Vygon Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 106. Vygon Interventional Lung Disease Product Portfolios and Specifications
Table 107. Vygon Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Vygon Main Business
Table 109. Vygon Latest Developments
Table 110. PENTAX Medical Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 111. PENTAX Medical Interventional Lung Disease Product Portfolios and Specifications
Table 112. PENTAX Medical Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. PENTAX Medical Main Business
Table 114. PENTAX Medical Latest Developments
Table 115. Clarus Medical Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 116. Clarus Medical Interventional Lung Disease Product Portfolios and Specifications
Table 117. Clarus Medical Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Clarus Medical Main Business
Table 119. Clarus Medical Latest Developments
Table 120. HUGER Medical Instrument Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 121. HUGER Medical Instrument Interventional Lung Disease Product Portfolios and Specifications
Table 122. HUGER Medical Instrument Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. HUGER Medical Instrument Main Business
Table 124. HUGER Medical Instrument Latest Developments
Table 125. Richard Wolf Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 126. Richard Wolf Interventional Lung Disease Product Portfolios and Specifications
Table 127. Richard Wolf Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Richard Wolf Main Business
Table 129. Richard Wolf Latest Developments
Table 130. Karl Storz Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 131. Karl Storz Interventional Lung Disease Product Portfolios and Specifications
Table 132. Karl Storz Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Karl Storz Main Business
Table 134. Karl Storz Latest Developments
Table 135. Taewoong Medical Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 136. Taewoong Medical Interventional Lung Disease Product Portfolios and Specifications
Table 137. Taewoong Medical Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Taewoong Medical Main Business
Table 139. Taewoong Medical Latest Developments
Table 140. ELLA - CS Basic Information, Interventional Lung Disease Manufacturing Base, Sales Area and Its Competitors
Table 141. ELLA - CS Interventional Lung Disease Product Portfolios and Specifications
Table 142. ELLA - CS Interventional Lung Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. ELLA - CS Main Business
Table 144. ELLA - CS Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Interventional Lung Disease
Figure 2. Interventional Lung Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interventional Lung Disease Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Interventional Lung Disease Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Interventional Lung Disease Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Interventional Lung Disease Sales Market Share by Country/Region (2024)
Figure 10. Interventional Lung Disease Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Bronchoscopes
Figure 12. Product Picture of Respiratory Endotherapy Devices
Figure 13. Product Picture of ENB Systems
Figure 14. Product Picture of Pleuroscopes
Figure 15. Product Picture of Other
Figure 16. Global Interventional Lung Disease Sales Market Share by Type in 2025
Figure 17. Global Interventional Lung Disease Revenue Market Share by Type (2020-2025)
Figure 18. Interventional Lung Disease Consumed in Hospital
Figure 19. Global Interventional Lung Disease Market: Hospital (2020-2025) & (K Units)
Figure 20. Interventional Lung Disease Consumed in Emergency Center
Figure 21. Global Interventional Lung Disease Market: Emergency Center (2020-2025) & (K Units)
Figure 22. Interventional Lung Disease Consumed in Clinic
Figure 23. Global Interventional Lung Disease Market: Clinic (2020-2025) & (K Units)
Figure 24. Global Interventional Lung Disease Sale Market Share by Application (2024)
Figure 25. Global Interventional Lung Disease Revenue Market Share by Application in 2025
Figure 26. Interventional Lung Disease Sales by Company in 2025 (K Units)
Figure 27. Global Interventional Lung Disease Sales Market Share by Company in 2025
Figure 28. Interventional Lung Disease Revenue by Company in 2025 ($ millions)
Figure 29. Global Interventional Lung Disease Revenue Market Share by Company in 2025
Figure 30. Global Interventional Lung Disease Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Interventional Lung Disease Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Interventional Lung Disease Sales 2020-2025 (K Units)
Figure 33. Americas Interventional Lung Disease Revenue 2020-2025 ($ millions)
Figure 34. APAC Interventional Lung Disease Sales 2020-2025 (K Units)
Figure 35. APAC Interventional Lung Disease Revenue 2020-2025 ($ millions)
Figure 36. Europe Interventional Lung Disease Sales 2020-2025 (K Units)
Figure 37. Europe Interventional Lung Disease Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Interventional Lung Disease Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Interventional Lung Disease Revenue 2020-2025 ($ millions)
Figure 40. Americas Interventional Lung Disease Sales Market Share by Country in 2025
Figure 41. Americas Interventional Lung Disease Revenue Market Share by Country (2020-2025)
Figure 42. Americas Interventional Lung Disease Sales Market Share by Type (2020-2025)
Figure 43. Americas Interventional Lung Disease Sales Market Share by Application (2020-2025)
Figure 44. United States Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Interventional Lung Disease Sales Market Share by Region in 2025
Figure 49. APAC Interventional Lung Disease Revenue Market Share by Region (2020-2025)
Figure 50. APAC Interventional Lung Disease Sales Market Share by Type (2020-2025)
Figure 51. APAC Interventional Lung Disease Sales Market Share by Application (2020-2025)
Figure 52. China Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 56. India Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Interventional Lung Disease Sales Market Share by Country in 2025
Figure 60. Europe Interventional Lung Disease Revenue Market Share by Country (2020-2025)
Figure 61. Europe Interventional Lung Disease Sales Market Share by Type (2020-2025)
Figure 62. Europe Interventional Lung Disease Sales Market Share by Application (2020-2025)
Figure 63. Germany Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 64. France Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Interventional Lung Disease Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Interventional Lung Disease Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Interventional Lung Disease Sales Market Share by Application (2020-2025)
Figure 71. Egypt Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Interventional Lung Disease Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Interventional Lung Disease in 2025
Figure 77. Manufacturing Process Analysis of Interventional Lung Disease
Figure 78. Industry Chain Structure of Interventional Lung Disease
Figure 79. Channels of Distribution
Figure 80. Global Interventional Lung Disease Sales Market Forecast by Region (2026-2031)
Figure 81. Global Interventional Lung Disease Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Interventional Lung Disease Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Interventional Lung Disease Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Interventional Lung Disease Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Interventional Lung Disease Revenue Market Share Forecast by Application (2026-2031)